ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 113 filers reported holding ARGENX SE in Q4 2018. The put-call ratio across all filers is 1.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,229,075 | -78.4% | 2,500 | -95.0% | 0.40% | -72.2% |
| Q3 2019 | $5,698,000 | -59.8% | 50,000 | -50.0% | 1.45% | -50.6% |
| Q2 2019 | $14,158,000 | +49.3% | 100,000 | -20.0% | 2.94% | +45.8% |
| Q3 2018 | $9,480,000 | -23.7% | 125,000 | -16.7% | 2.02% | -44.9% |
| Q2 2018 | $12,429,000 | +3.0% | 150,000 | 0.0% | 3.66% | +49.9% |
| Q1 2018 | $12,066,000 | -23.6% | 150,000 | -40.0% | 2.44% | -34.1% |
| Q4 2017 | $15,785,000 | +176.4% | 250,000 | -1.0% | 3.70% | +205.2% |
| Q3 2017 | $5,710,000 | +37.2% | 252,534 | +28.7% | 1.21% | +40.2% |
| Q2 2017 | $4,163,000 | – | 196,287 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |